Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjögren's syndrome: Data from a placebo-controlled clinical trial

Pollard, R. P. E., Abdulahad, W. H., Vissink, A., Hamza, N., Burgerhof, J. G. M., Meijer, J. M., … Kroese, F. G. M. (2013, January). Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjögren’s syndrome: Data from a placebo-controlled clinical trial. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2012-202071